Pricing
NextPhase Therapeutics
Unverified
Contact
Carlos Paya is a board member of two publicly listed companies (NYSE and NASDAQ). He was President and CEO, Immune Design Corp, until its acquisition by Merck.
View org chart
This person is not in the org chart
View all teams
9 people, 0 jobs
View all offices
This person is not in any offices
PI Financial
Telaid
insitro
Opendoor
Saab Group
Mercy Corps
View more